What’s new in the renin-angiotensin system?
By Wenhui Li, M. J. Moore, N. Vasilieva, J. Sui, S. Wong, M. Berne, M. Somasundaran, J. Sullivan, K. Luzuriaga, T. Greenough and 2 more. 2004
2,744 citations recorded by the source corpus.
Abstract.Cellular entry of enveloped viruses is often dependent on attachment proteins expressed on the host cell surface. Viral envelope proteins bind these receptors, and, in an incompletely understood process, facilitate fusion of the cellular and viral membranes so as to introduce the viral core into the cytoplasm. Only a small fraction of viral receptors have been identified so far. Recently, a novel coronavirus was identified as the etiological agent of severe acute respiratory syndrome (SARS). The fusion protein gene of SARS coronavirus (SARS-CoV) was cloned and characterized, and shortly thereafter, angiotensin-converting enzyme 2 (ACE2) was shown to be its functional receptor. Identification of ACE2 as a receptor for SARS-CoV will likely contribute to the development of antivirals and vaccines. It may also contribute to the development of additional animal models for studying SARS pathogenesis, and could help identify the animal reservoir of SARS-CoV.
Subfields: Animal Science and Zoology, Infectious Diseases
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Animal Science and Zoology
- P. Masters
- Kwok-Yung Yuen
- S. Weiss
- Patrick C. Y. Woo
- Susanna K. P. Lau
- Ralph S. Baric
- S. Perlman
- Gary R. Whittaker
In Infectious Diseases
- P. Masters
- Ralph S. Baric
- Kwok-Yung Yuen
- J. Millet
- S. Weiss
- Gary R. Whittaker
- Patrick C. Y. Woo
- Rachel L. Graham
Citations in the corpus
- Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme (2015, background): “hCoV-NL63 and SARS-CoV both employ human angiotensin-converting enzyme 2 (ACE2) to mediate cellular entry (11, 12), while hCoV-NL63 utilizes heparan sulfate proteoglycans for attachment to target cells (13).”
- Coronavirus Diversity, Phylogeny and Interspecies Jumping (2009, background): “It is also noteworthy that at least one member of group 1b, HCoV-NL63, also uses ACE2 as the receptor for cell entry, as in the case of SARS-CoV, though the site of binding on ACE2 is different (52, 53).”
- SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS (2009, background): “Angiotensin converting enzyme 2 is the functional receptor for the SARS-CoV and mediates SARS-CoV pulmonary infection [8, 10] .”
- SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far (2020, background): “Initial in vitro results have shown promising results [67,68] and specific monoclonal antibodies are being contemplated as candidates for treatment [69,70].”
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes (2009, background): “SARS-CoV infection is mediated by the binding of its spike (S) protein to a cellular receptor on its target cells, and a recent study proved that ACE2 is a functional receptor for SARS-CoV S protein [4, 5].”
- Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus (2006, background): “With the goal of developing a more robust murine model, we generated transgenic (Tg) mice in which expression of hACE2 (human angiotensin-converting enzyme 2, the primary host cell receptor for SARS-CoV [23]) was targeted to epithelial cells.”
- A decade after SARS: Strategies to control emerging coronaviruses (2013, background): “The receptor-binding domain (RBD) of the spike glycoprotein is poorly conserved among viruses and, as a result, host receptor usage varies between viral genera and species 37, 38, 132 .”
- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics (2020, background): “…as the receptor binding domain for its spike protein (Lu et al., 2020; Wan, Shang, Graham, Baric, & Li, 2020), similarly to the coronavirus strain implicated in the 2002–2003 SARS epidemic (Dimitrov, 2003; Ge et al., 2013; Li et al., 2003; Prabakaran et al 2004; Turner, Hiscox, & Hooper, 2004).”
- Coronaviruses post-SARS: Update on replication and pathogenesis (2009, background): “SARS-CoV, a group 2 coronavirus, enters host cells through an interaction of the S protein with human angiotensin converting enzyme 2 ( ACE2”